Haplotype Analysis of Vitamin D Receptor (VDR) Gene in Breast Cancer Patients

被引:2
作者
Ergul, Emel [1 ]
Simsek, Turgay [2 ]
Uren, Nihal [1 ]
Korak, Tugcan [1 ]
Simsek, Hayal U. [3 ]
Cine, Naci [4 ]
Canturk, N. Zafer [2 ]
Utkan, N. Zafer [2 ]
机构
[1] Kocaeli Univ, Fac Med, Dept Med Biol, Kocaeli, Turkey
[2] Kocaeli Univ, Fac Med, Dept Gen Surg, Kocaeli, Turkey
[3] Kocaeli Univ, Dept Obstet & Gynecol, Kocaeli, Turkey
[4] Kocaeli Univ, Fac Med, Dept Med Genet, Kocaeli, Turkey
关键词
breast cancer; haplotype analysis; polymorphism; VDR gene; POLYMORPHISMS; RISK; ASSOCIATION; VARIANTS; DISEASE; BSMI;
D O I
10.7754/Clin.Lab.2020.200931
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: The aim of the study was to evaluate the role of well-characterized vitamin D receptor (VDR) gene polymorphisms, BsmI (rs 1544410), ApaI (rs 7975232), TaqI (rs 731236), and FokI (rs 10735810) and their haplotypes in the pathogenesis of breast cancer in Turkish women. Methods: The subjects consisted of women including 331 breast cancer patients and 345 healthy controls. After conventional DNA isolation genotyping was done by a PCR-RFLP method, haplotype analysis was performed using Haploview 4.2. Results: Haplotype analysis in different combinations revealed that frequencies of Fbt, fbt, bAt, and bt haplotypes are significantly higher in breast cancer patients than controls (chi(2) = 6.862, p = 0.0088; chi(2) = 4.176, p = 0.041; chi(2) = 4.184, p = 0.0408; chi(2) = 8.409, p = 0.0037 respectively). However, no statistically significant difference between genotypes of cases and controls were found when analyzed separately. Conclusions: All these data support the hypothesis that it is crucial to evaluate VDR gene polymorphism by haplotype analysis in order to understand how changes in VDR sequence influence the function of the VDR gene and how this variability affects the risk of breast cancer.
引用
收藏
页码:1421 / 1427
页数:7
相关论文
共 37 条
  • [1] Vitamin D receptor gene polymorphisms and haplotypes and postmenopausal breast cancer risk
    Abbas, Sascha
    Nieters, Alexandra
    Linseisen, Jakob
    Slanger, Tracy
    Kropp, Silke
    Mutschelknauss, Elke Jonny
    Flesch-Janys, Dieter
    Chang-Claude, Jenny
    [J]. BREAST CANCER RESEARCH, 2008, 10 (02)
  • [2] Vitamin D receptor gene polymorphisms and breast cancer risk among postmenopausal Egyptian women
    Abd-Elsalam, Eman Abd-Elkader
    Ismaeil, Nadia A.
    Abd-Alsalam, Hoda Sibai
    [J]. TUMOR BIOLOGY, 2015, 36 (08) : 6425 - 6431
  • [3] Vitamin D receptor polymorphisms or serum levels as key drivers of breast cancer development? The question of the vitamin D pathway
    Amadori, Dino
    Serra, Patrizia
    Masalu, Nestory
    Pangan, Akwilina
    Scarpi, Emanuela
    Bugingo, Aloyce Maria
    Katabalo, Deogratias
    Ibrahim, Toni
    Bongiovanni, Alberto
    Miserocchi, Giacomo
    Spadazzi, Chiara
    Liverani, Chiara
    Turri, Valentina
    Tedaldi, Rosanna
    Mercatali, Laura
    [J]. ONCOTARGET, 2017, 8 (08) : 13142 - 13156
  • [4] Vitamin D-Related Genetic Variants, Interactions with Vitamin D Exposure, and Breast Cancer Risk among Caucasian Women in Ontario
    Anderson, Laura N.
    Cotterchio, Michelle
    Cole, David E. C.
    Knight, Julia A.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2011, 20 (08) : 1708 - 1717
  • [5] CLONING AND EXPRESSION OF FULL-LENGTH CDNA-ENCODING HUMAN VITAMIN-D RECEPTOR
    BAKER, AR
    MCDONNELL, DP
    HUGHES, M
    CRISP, TM
    MANGELSDORF, DJ
    HAUSSLER, MR
    PIKE, JW
    SHINE, J
    OMALLEY, BW
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (10) : 3294 - 3298
  • [6] The Relationship between Urothelial Type Bladder Cancer, Plasma 25-Hydroxyvitamin D Levels, and Vitamin D Receptor ApaI BsmI FokI, and TaqI Polymorphisms
    Baykan, Ozgur
    Akgul, Murat
    Uren, Nihal
    Yaman, Ali
    Tinay, Ilker
    Ergul, Emel
    Sazci, Ali
    Turkeri, Levent
    Haklar, Goncagul
    [J]. CLINICAL LABORATORY, 2019, 65 (04) : 445 - 452
  • [7] Vitamin D receptor gene polymorphisms in breast cancer
    Buyru, N
    Tezol, A
    Yosunkaya-Fenerci, E
    Dalay, N
    [J]. EXPERIMENTAL AND MOLECULAR MEDICINE, 2003, 35 (06) : 550 - 555
  • [8] Associations between Polymorphisms in the vitamin D receptor and breast cancer risk
    Chen, WY
    Bertone-Johnson, ER
    Hunter, DJ
    Willett, WC
    Hankinson, SE
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (10) : 2335 - 2339
  • [9] Curran JE, 1999, INT J CANCER, V83, P723, DOI 10.1002/(SICI)1097-0215(19991210)83:6<723::AID-IJC4>3.0.CO
  • [10] 2-3